Abstract
Purpose
To evaluate the efficacy of povidone–iodine (PI) in reducing the risk of infectious complications following transrectal prostate biopsy (TRPB).
Methods
Eligible randomized controlled trials (RCTs) were identified from electronic databases (Cochrane CENTRAL, MEDLINE, and EMBASE). The database search, quality assessment, and data extraction were performed independently by two reviewers. The main outcome for the efficacy of PI was the incidence of infectious complications after TRPB.
Results
Seven trials, including 2,049 patients, met the inclusion criteria. Data from the seven included RCTs favored the use of PI before TRPB to prevent infectious complications. PI for “PI versus blank control” significantly reduced fever, bacteriuria, and bacteremia compared with that for control [relative risk (RR) 0.31; 95 % confidence interval (CI) 0.21–0.45, P < 0.00001]. With PI versus antibiotics (ATB), patients treated with ATB alone had a significantly greater risk of bacteremia (RR 0.38; 95 % CI 0.16–0.90, P = 0.03). In “PI plus ATB versus ATB” trials, the risk of fever (RR 0.11; 95 % CI 0.02–0.85, P = 0.03) and bacteremia (RR 0.25; 95 % CI 0.08–0.75, P = 0.01) was diminished in the “PI plus ATB” group.
Conclusions
Rectal disinfection with PI provides a safe and effective method to reduce the risk of infectious complications following TRPB, regardless of mono-prophylaxis and combined prophylaxis with PI and ATB. Large, multicenter, and prospective RCTs of good quality trials are needed to confirm the efficacy of PI.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11–30
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403
Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71
Loeb S, van den Heuvel S, Zhu X et al (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61(6):1110–1114
Nam RK, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12–S18
Zani EL, Clark OA, Rodrigues NNJ (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 5:D6576
Steensels D, Slabbaert K, De Wever L et al (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy—should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18(6):575–581
Wagenlehner FM, van Oostrum E, Tenke P et al (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521–527
Pattana-arun J, Wolff BG (2008) Benefits of povidone–iodine solution in colorectal operations: science or legend. Dis Colon Rectum 51(6):966–971
Lachapelle JM, Castel O, Casado AF et al (2013) Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin Pract 10(5):579–592
Park DS, Oh JJ, Lee JH et al (2009) Simple use of the suppository type povidone–iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol 2009:750598
Kanjanawongdeengam P, Viseshsindh W, Santanirand P et al (2009) Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial. J Med Assoc Thai 92(12):1621–1626
Abughosh Z, Margolick J, Goldenberg SL et al (2013) A prospective randomized trial of povidone–iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326–1331
Higgins J, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. In the Cochrane Library, Issue 3, Wiley, Chichester
Brown RW, Warner JJ, Turner BI et al (1981) Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 18(2):145–148
Melekos MD (1990) Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 22(3):257–262
Huang YC, Ho DR, Wu CF et al (2006) Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J 29(4):395–400
Ghafoori M, Shakiba M, Seifmanesh H et al (2012) Decrease in infection rate following use of povidone–iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol 9(2):67–70
Akay AF, Akay H, Aflay U et al (2006) Prevention of pain and infective complications after transrectal prostate biopsy: a prospective study. Int Urol Nephrol 38(1):45–48
Taylor S, Margolick J, Abughosh Z et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111(6):946–953
Shigemura K, Arakawa S, Nakano Y et al (2006) Larger prostate causes higher frequency of infectious complications in prostate biopsy. Urol Int 76(4):321–326
Obek C, Onal B, Ozkan B et al (2002) Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy associated with increased infectious or hemorrhagic complications? A prospective randomized trial. J Urol 168(2):558–561
Rees A, Sherrod Q, Young L (2011) Chemical burn from povidone–iodine: case and review. J Drugs Dermatol 10(4):414–417
Ono T, Kushikata T, Tsubo T et al (2011) A case of asystole following povidone iodine administration. Masui 60(4):499–501
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grant Nos. 30901484, 81270841) and Pillar Program from Science and Technology Department of Sichuan Province (Grant No. 2013SZ0034).
Conflict of interest
The author declares that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Chunxiao Pu and Yunjin Bai contributed equally to this work and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Pu, C., Bai, Y., Yuan, H. et al. Reducing the risk of infection for transrectal prostate biopsy with povidone–iodine: a systematic review and meta-analysis. Int Urol Nephrol 46, 1691–1698 (2014). https://doi.org/10.1007/s11255-014-0713-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0713-2